Semax: gene-expression findings in an experimental stroke model

Evidence discussed: Rat brain-ischemia study.

What the researchers studied

Researchers examined Semax and Pro-Gly-Pro in rats after an experimentally induced interruption of brain blood supply. They measured neurotrophin and receptor gene expression at multiple time points, finding changes dependent on peptide and timing. [1]

How to interpret the result

Gene-expression shifts are not direct evidence of better human memory, post-stroke independence or survival. An induced animal injury also differs from clinical stroke. Results for Pro-Gly-Pro cannot automatically be assigned to Semax.

What readers can take from it

The measured transcription patterns offer a biological hypothesis. Demonstrating treatment benefits in a person requires a different level of evidence.

This original editorial summary provides no diagnosis, dosing or treatment advice. The study did not test or certify a PeptiKing product.

Source

[1] Dmitrieva et al., Semax and neurotrophin transcription (2010). PMID: 19633950. Based on the PubMed-indexed abstract and record; full-text methods were not independently reviewed.